News & Events
Category: Events 20 July 2023
QP Forum 2023
Michael Hildebrand will attend the Qualified Person Forum in Vienna, 12-13 October 2023.
Category: Events 20 July 2023
The GLA Biotech & Pharma Summer School
Michael Hildebrand and Wolf-Stefan Richter und Jens Hoffmann will present at “From Target to Market – The GLA Biotech & Pharma Summer School” from August 30 to September 2 in Berlin.
Category: Events 20 December 2022
Jens Hoffmann is a co-organizer of 21st International AEK Cancer Congress 2023
As speaker for the working group “New Therapies” in the German Cancer Research Organization (DKG/AEK), Jens Hoffmann is involved in the organization of the 21st International AEK Cancer Congress “Towards New Cancer Therapies: Mechanisms and Molecules” which will take place on February 15 - 17, 2023 at the Kongress Palais in Kassel (Germany).
Category: Events 2 December 2022
17th QP Forum
Pre-Conference Session IMPs PLUS Conference
Berlin 30.11.-02.12.2022
Category: Press Releases 29 November 2022
Sprachpate bei Kitakindern
Die "Berliner Zeitung" berichtet über Matthias Bräutigams ehrenamtliche Tätigkeit als Sprachpate für Berliner Kinder, die Sprachschwierigkeiten haben.
Was Sprachpaten mit Kitakindern erleben: „Er war wie in einer Schockstarre“
Category: Events 3 November 2022
17th QP Forum Pre-Conference Session IMPs PLUS Conference in Berlin
Michael Hildebrand will attend the 17th QP Forum Pre-Conference Session IMPs PLUS Conference in Berlin, November 30 to December 2, 2022
Category: Events 25 October 2022
ECTRIMS 2022 Amsterdam
Christian Wolf will attend the congress of the European Committee on Treatment and Research in Multiple Sclerosis from 26-28 October 2022 in Amsterdam in person.
Category: Events 21 October 2022
26th General Assembly - Autumn 2023
Conelis e.V. held its 26th General Assembly on 21 October 2021 in Berlin.
Christian Wolf, Jörg Täubel, and Frank Zollmann will continue to represent the association as the acting Executive Board.
Category: Events 29 September 2022
Workshop: Get the most out of scientific literature
Thursday, 29 September 2022, 5:00 pm – 5:30 pm
Category: Publications 24 August 2022
How to use biosimilars and generic NBCDs as DMTs for Multiple Sclerosis?
Co-authored by Christian Wolf:
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations.
Wallace J Brownlee, Christian Wolf, Hans-Peter Hartung, Theo Dingermann, Nadia Anshasi, Richard AC Clark, Maria Trojano, Krzysztof Selmaj, Bernard MJ Uitdehaag, Carmen Tur, Jens Wuerfel, Gabriele Dallmann, Julian Witte, Martina Sintzel, Olga Bobrovnikova, and Jeffrey A Cohen.
Mult Scler J. 2022; 135245852211162. (abstract).